Diabetes in Practice: Case Studies with Commentary
In the best tradition of medical practice, this essential text shares a wealth of insight into some of the most challenging diagnoses and clinical experiences from leading diabetologists around the world.
Regardless of where a clinician is in their practice, learning never ends. The 49 detailed case studies presented in Diabetes in Practice can broaden understanding and elevate patient care across the spectrum of settings.
Further, expert commentaries by Mary Korytkowski, MD, Louis Philipson, MD, PhD, Anne Peters, MD, and Boris Draznin, MD, PhD, highlight the important lessons and takeaways from each case.
This collection has been carefully curated to enhance diabetes practice, and addresses such topics as:
Atypical Diabetes
Diabetic Ketoacidosis (DKA) and Euglycemic DKA
Cancer Therapy and Diabetes
Autoimmunity and Diabetes
Continuous Glucose Monitoring (CGM) and Insulin Pumps
Hypoglycemia, and more
Download citation file:
Table of Contents
-
Part 1: Atypical Diabetes
-
Case 1: Suspected Maturity-Onset Diabetes of the Young (MODY)-5 (MODY-HNF1B) Responding to Monotherapy With MetforminByAna Ramirez Berlioz, MD;Ana Ramirez Berlioz, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:Richa Patel, MD;Richa Patel, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:David Gardner, MD;David Gardner, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:L. Romayne Kurukulasuriya, MD;L. Romayne Kurukulasuriya, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:James Sowers, MDJames Sowers, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:
-
Case 2: Maturity-Onset Diabetes of the Young (MODY)-4 Presenting as Gestational DiabetesByIvana Sheu, MD;Ivana Sheu, MD1University of California Irvine Diabetes Center and Department of Medicine, Irvine, California.Search for other works by this author on:Yung-In Choi, MD;Yung-In Choi, MD1University of California Irvine Diabetes Center and Department of Medicine, Irvine, California.Search for other works by this author on:Samar Singh, MD;Samar Singh, MD1University of California Irvine Diabetes Center and Department of Medicine, Irvine, California.Search for other works by this author on:Ping H. Wang, MDPing H. Wang, MD1University of California Irvine Diabetes Center and Department of Medicine, Irvine, California.Search for other works by this author on:
-
Case 3: Does This Patient Have Type 1 or Type 2 Diabetes?ByZubina Unjom, MD;Zubina Unjom, MD1Diabetes/Endocrinology Section, Chicago Medical School, Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Janice L. Gilden, MS, MDJanice L. Gilden, MS, MD1Diabetes/Endocrinology Section, Chicago Medical School, Rosalind Franklin University of Medicine and Science.2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:
-
Case 4: Is This an Unusual Type of Diabetes?ByNitish Singh Nandu, MD;Nitish Singh Nandu, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Andriy Havrylyan, MD;Andriy Havrylyan, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Janice L. Gilden, MS, MD;Janice L. Gilden, MS, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:Bushra Osmani, MBBSBushra Osmani, MBBS3Community Physicians at Froedtert and the Medical College of Wisconsin at Milwaukee, Milwaukee, Wisconsin.Search for other works by this author on:
-
Case 5: Challenges in the Management of Pancreatogenic (Type 3c) DiabetesByKatrina Han, MD;Katrina Han, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri.Search for other works by this author on:Janet B. McGill, MDJanet B. McGill, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri.Search for other works by this author on:
-
Case 6: New-Onset Diabetes as a Symptom of Pancreatic AdenocarcinomaByEmily Gammoh, MD;Emily Gammoh, MD1University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Center for Diabetes and Endocrinology, Pittsburgh, Pennsylvania.Search for other works by this author on:Jagdeesh Ullal, MDJagdeesh Ullal, MD1University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Center for Diabetes and Endocrinology, Pittsburgh, Pennsylvania.Search for other works by this author on:
-
Case 7: Sweet’s Syndrome in a Patient With DiabetesByNitish Singh Nandu, MD;Nitish Singh Nandu, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Sabah Patel, MD;Sabah Patel, MD2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:Janice L. Gilden, MS, MDJanice L. Gilden, MS, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:
-
Case 8: Wolcott-Rallison SyndromeByMehmet N. Özbek, MD;Mehmet N. Özbek, MD1Gazi Yasargil Training and Research Hospital Clinics of Pediatric Endocrinology, Diyarbakır, Turkey.Search for other works by this author on:Eda Cengiz, MD, MHS, FAAPEda Cengiz, MD, MHS, FAAP2Division of Pediatric Endocrinology and Diabetes, Yale School of Medicine, New Haven, Connecticut.3Visiting Professor, Bahcesehir University, Istanbul, Turkey.Search for other works by this author on:
-
Case 9: Glucose Intolerance Associated With ACTH-Dependent Cushing’s DiseaseByNitya K. Kumar, MD;Nitya K. Kumar, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:Susan Spratt, MDSusan Spratt, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:
-
Case 10: Maturity-Onset Diabetes of the Young (MODY) Misdiagnosis as Steroid-Induced DiabetesByGhada Elshimy, MD;Ghada Elshimy, MD1Division of Endocrinology, University of Arizona College of Medicine, Phoenix, Arizona.Search for other works by this author on:Ricardo Correa, MD, EdD, FACP, FACE, FAPCR, CMQRicardo Correa, MD, EdD, FACP, FACE, FAPCR, CMQ1Division of Endocrinology, University of Arizona College of Medicine, Phoenix, Arizona.Search for other works by this author on:
-
-
Part 2: Diabetic Ketoacidosis (DKA) and Euglycemic DKA
-
Case 11: A Case of Histiocytosis-Lymphadenopathy Plus Syndrome Due to a Novel Mutation in the SLC29A3 Gene and Presentation With Diabetic KetoacidosisByGül Yesiltepe-Mutlu, MD;Gül Yesiltepe-Mutlu, MD1Division of Pediatric Endocrinology and Diabetes, Koç University School of Medicine, Istanbul, Turkey.Search for other works by this author on:Mehmet N. Özbek, MD;Mehmet N. Özbek, MD2Gazi Yasargil Training and Research Hospital Clinics of Pediatric Endocrinology, Diyarbakır, Turkey.Search for other works by this author on:Eda Cengiz, MD, MHS, FAAPEda Cengiz, MD, MHS, FAAP3Division of Pediatric Endocrinology and Diabetes, Yale School of Medicine, New Haven, Connecticut.4Visiting Professor, Bahcesehir University, Istanbul, Turkey.Search for other works by this author on:
-
Case 12: Acromegaly Presenting With Diabetic KetoacidosisByRitika Verma, MD;Ritika Verma, MD1Internal Medicine, University of Missouri, Columbia, Missouri.Search for other works by this author on:Kiet Huynh, BS;Kiet Huynh, BS1Internal Medicine, University of Missouri, Columbia, Missouri.Search for other works by this author on:Rajani Gundluru, MD;Rajani Gundluru, MD2Endocrinology and Diabetes Division, University of Missouri School of Medicine, Columbia, Missouri.Search for other works by this author on:Michael J. Gardner, MD;Michael J. Gardner, MD2Endocrinology and Diabetes Division, University of Missouri School of Medicine, Columbia, Missouri.Search for other works by this author on:James Sowers, MDJames Sowers, MD2Endocrinology and Diabetes Division, University of Missouri School of Medicine, Columbia, Missouri.Search for other works by this author on:
-
Case 13: Rapid-Onset Type 1 Diabetes and KetoacidosisByDeepthi Rimmalapudi, MD;Deepthi Rimmalapudi, MD1Lundquist Research Institute at Harbor-UCLA Medical Center, Torrance, California.Search for other works by this author on:Eli Ipp, MDEli Ipp, MD1Lundquist Research Institute at Harbor-UCLA Medical Center, Torrance, California.Search for other works by this author on:
-
Case 14: Euglycemic Ketoacidosis in the Setting of COVID-19 Infection and Sodium–Glucose Cotransporter 2 Inhibitor UseByOlga Duchon, MD;Olga Duchon, MD1Endocrinology, University of Chicago Medicine, Chicago, Illinois.Search for other works by this author on:Celeste Thomas, MDCeleste Thomas, MD1Endocrinology, University of Chicago Medicine, Chicago, Illinois.Search for other works by this author on:
-
Case 15: Euglycemic Diabetic Ketoacidosis Due to Sodium–Glucose Cotransporter 2 Inhibitor UseByDiana Soliman, MD;Diana Soliman, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:Nicole Jelesoff, MDNicole Jelesoff, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:
-
Case 16: A Case of Euglycemic Diabetic Ketoacidosis After Initiation of Ketogenic Diet in a Patient With Type 2 Diabetes on a Sodium–Glucose Cotransporter 2 (SGLT2) InhibitorByMatthew P. Gilbert, DO, MPH;Matthew P. Gilbert, DO, MPH1Department of Medicine, Division of Endocrinology and Diabetes, Larner College of Medicine at The University of Vermont, Burlington, Vermont.Search for other works by this author on:Amy Shah, DOAmy Shah, DO1Department of Medicine, Division of Endocrinology and Diabetes, Larner College of Medicine at The University of Vermont, Burlington, Vermont.Search for other works by this author on:
-
Case 17: Diabetic Ketoacidosis in End-Stage Renal Disease: A Unique ChallengeByVishnu Garla, MD;Vishnu Garla, MD1Department of Internal Medicine, Mississippi Center for Clinical and Translational Research (MCCTR), University of Mississippi Medical Center, Jackson, Mississippi.2Division of Endocrinology, Metabolism, and Diabetes, University of Mississippi Medical Center, Jackson, Mississippi.Search for other works by this author on:Angela Subauste, MD;Angela Subauste, MD2Division of Endocrinology, Metabolism, and Diabetes, University of Mississippi Medical Center, Jackson, Mississippi.Search for other works by this author on:Lillian F. Lien, MDLillian F. Lien, MD2Division of Endocrinology, Metabolism, and Diabetes, University of Mississippi Medical Center, Jackson, Mississippi.Search for other works by this author on:
-
Case 18: Euglycemic Diabetic Ketoacidosis in a Patient With Type 1 Diabetes Treated With a Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor While on a Ketogenic DietByJessica Castellanos-Diaz, MD;Jessica Castellanos-Diaz, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Malcom Randall Veteran Hospital, Gainesville, Florida.2Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, Florida.Search for other works by this author on:Julio Leey-Casella, MD;Julio Leey-Casella, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Malcom Randall Veteran Hospital, Gainesville, Florida.2Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, Florida.Search for other works by this author on:Kenneth Cusi, MD;Kenneth Cusi, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Malcom Randall Veteran Hospital, Gainesville, Florida.2Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, Florida.Search for other works by this author on:Sushma Kadiyala, MDSushma Kadiyala, MD1Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Malcom Randall Veteran Hospital, Gainesville, Florida.2Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, Florida.Search for other works by this author on:
-
-
Part 3: Cancer Therapy and Diabetes
-
Case 19: Immune Checkpoint Inhibitor–Induced Type 1 DiabetesByHalis Kaan Akturk, MD;Halis Kaan Akturk, MD1Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado.Search for other works by this author on:Aaron W. Michels, MDAaron W. Michels, MD1Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado.Search for other works by this author on:
-
Case 20: Partial β-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor DiabetesByZoe Quandt, MD;Zoe Quandt, MD1Division of Endocrinology and Metabolism.Search for other works by this author on:Paras Mehta, MD;Paras Mehta, MD1Division of Endocrinology and Metabolism.Search for other works by this author on:Katy K. Tsai, MD;Katy K. Tsai, MD2Division of Hematology/Oncology, University of California, San Francisco, California.Search for other works by this author on:Victoria Hsiao, MD;Victoria Hsiao, MD1Division of Endocrinology and Metabolism.Search for other works by this author on:Robert J. Rushakoff, MDRobert J. Rushakoff, MD1Division of Endocrinology and Metabolism.Search for other works by this author on:
-
Case 21: Checkpoint Inhibitor–Induced DiabetesByParas Mehta, MD;Paras Mehta, MD1Division of Endocrinology and Metabolism, University of California, San Francisco, California.Search for other works by this author on:Zoe Quandt, MD;Zoe Quandt, MD1Division of Endocrinology and Metabolism, University of California, San Francisco, California.Search for other works by this author on:Robert J. Rushakoff, MDRobert J. Rushakoff, MD1Division of Endocrinology and Metabolism, University of California, San Francisco, California.Search for other works by this author on:
-
Case 22: Alpelisib-Induced Hyperglycemia: A Case SeriesByRicha Patel, MD;Richa Patel, MD1Department of Medicine, Division of Endocrinology and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:Ana Ramirez Berlioz, MD;Ana Ramirez Berlioz, MD1Department of Medicine, Division of Endocrinology and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:Amber Pinson, MD;Amber Pinson, MD1Department of Medicine, Division of Endocrinology and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:Michael Gardner, MDMichael Gardner, MD1Department of Medicine, Division of Endocrinology and Metabolism, University of Missouri–Columbia, Columbia, Missouri.Search for other works by this author on:
-
Case 23: Phosphatidylinositol 3-Kinase (PI3K) Inhibitor–Induced HyperglycemiaBySanjita B. Chittimoju, MD;Sanjita B. Chittimoju, MD1Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.Search for other works by this author on:Sara M. Alexanian, MD;Sara M. Alexanian, MD1Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.Search for other works by this author on:Katherine L. Modzelewski, MDKatherine L. Modzelewski, MD1Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.Search for other works by this author on:
-
-
Part 4: Autoimmunity and Diabetes
-
Case 24: Misleading Diabetes: A Case of Type B Insulin Resistance Associated With Lupus Nephritis and Autoimmune HepatitisByGhada Elshimy;Ghada Elshimy1Division of Endocrinology, University of Arizona College of Medicine, Phoenix, Arizona.Search for other works by this author on:Mary Esquivel;Mary Esquivel2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:Meredith McFarland;Meredith McFarland2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:Jessica Ricciuto;Jessica Ricciuto2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:Christopher Tessier;Christopher Tessier2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:Joanna Miragaya;Joanna Miragaya2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:Ricardo Correa, MD, EDD, FACP, FACE, FAPCR, CMQRicardo Correa, MD, EDD, FACP, FACE, FAPCR, CMQ1Division of Endocrinology, University of Arizona College of Medicine, Phoenix, Arizona.2Division of Endocrinology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.Search for other works by this author on:
-
Case 25: Latent Autoimmune Diabetes in an Adult With Insulin AllergyByMakeda Dawkins, MD;Makeda Dawkins, MD1Department of Medicine, Westchester Medical Center, Valhalla, New York.Search for other works by this author on:Alyson K. Myers, MDAlyson K. Myers, MD2Department of Medicine, Division of Endocrinology, North Shore University Hospital, Northwell Health, Manhasset, New York.3Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.4Center for Health Innovations and Health Outcomes Research.5Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York.Search for other works by this author on:
-
Case 26: Onset of Autoimmune Diabetes During PregnancyByKaitlyn Barrett, DO;Kaitlyn Barrett, DO1Department of Medicine, Division of Endocrinology and Diabetes, Larner College of Medicine at The University of Vermont, Burlington, Vermont.Search for other works by this author on:Kelsey Sheahan, MD;Kelsey Sheahan, MD1Department of Medicine, Division of Endocrinology and Diabetes, Larner College of Medicine at The University of Vermont, Burlington, Vermont.Search for other works by this author on:Matthew P. Gilbert, DO, MPHMatthew P. Gilbert, DO, MPH1Department of Medicine, Division of Endocrinology and Diabetes, Larner College of Medicine at The University of Vermont, Burlington, Vermont.Search for other works by this author on:
-
Case 27: Comorbidity of Diabetes and Systemic Lupus ErythematosusByBoris Mankovsky, MD;Boris Mankovsky, MD1Department of Diabetology, National Medical Academy for Postgraduate Education.2Center for Innovative Medical Technologies, Kiev, Ukraine.Search for other works by this author on:Yanina Saenko, MDYanina Saenko, MD2Center for Innovative Medical Technologies, Kiev, Ukraine.Search for other works by this author on:
-
Case 28: Illusion of Autoimmune DiabetesByNay Linn Aung, MDNay Linn Aung, MD1St. Elizabeth Family Medicine Residency, Mohawk Valley Health System (MVHS), Utica, New York.Search for other works by this author on:
-
Case 29: Can a Lupus Flare Cause Autoimmune Diabetes?ByAndriy Havrylyan, MD;Andriy Havrylyan, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Janice L. Gilden, MS, MDJanice L. Gilden, MS, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:
-
-
Part 5: Continuous Glucose Monitoring (CGM) and Insulin Pumps
-
Case 30: Feasibility and Utility of Continuous Glucose Monitoring in an Adult With Type 1 Diabetes and Down’s SyndromeByKristen L. Flint, MD;Kristen L. Flint, MD1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.Search for other works by this author on:Elena Toschi, MDElena Toschi, MD1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.2Joslin Diabetes Center, Boston, Massachusetts.Search for other works by this author on:
-
Case 31: A Novel Approach to Achieve Target Time in Range When Using U-500 Regular Insulin in a Continuous Subcutaneous Insulin Infusion (CSII) PumpByPatricia A. Montesinos, NP, CDE;Patricia A. Montesinos, NP, CDE1MedStar Diabetes Institute.Search for other works by this author on:Michelle F. Magee, MD, MBBCh, BAO, LRCPSIMichelle F. Magee, MD, MBBCh, BAO, LRCPSI1MedStar Diabetes Institute.2Georgetown University School of Medicine, Washington, DCSearch for other works by this author on:
-
Case 32: Automated Insulin Infusion System Is Useful to Control Blood Glucose Concentration During Major Stress in Patients With Type 1 DiabetesByRenzo Cordera, MD;Renzo Cordera, MD1Department of Internal Medicine, University of Genova and Policlinico San Martino, Genova, Italy.Search for other works by this author on:Davide Maggi, MD, PhDDavide Maggi, MD, PhD1Department of Internal Medicine, University of Genova and Policlinico San Martino, Genova, Italy.Search for other works by this author on:
-
Case 33: Detecting Patterns in Continuous Glucose Monitoring of Glucocorticoid-Treated Patients With DiabetesByHarjyot Sandhu, MD;Harjyot Sandhu, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:Janice L. Gilden, MS, MD;Janice L. Gilden, MS, MD1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.2Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois.Search for other works by this author on:Lynne Wentz, MHS, BSN, CDCESLynne Wentz, MHS, BSN, CDCES1Diabetes/Endocrinology Section, Chicago Medical School at Rosalind Franklin University of Medicine and Science.Search for other works by this author on:
-
-
Part 6: Hypoglycemia
-
Case 34: Hyperinsulemic Hypoglycemia After Roux-en-Y Gastric Bypass Surgery: Both Fasting and PostprandialByMaria Magar, MD;Maria Magar, MD1LAC+USC Medical Center, Los Angeles, CaliforniaSearch for other works by this author on:Anne Peters, MD;Anne Peters, MD2Keck School of Medicine of the University of Southern California, Los Angeles, California.Search for other works by this author on:Braden Barnett, MDBraden Barnett, MD3Keck School of Medicine of the University of Southern California, Los Angeles, CaliforniaSearch for other works by this author on:
-
Case 35: Refractory Hypoglycemia Due to Massive Unintentional Insulin OverdoseByJennifer D. Merrill, MD;Jennifer D. Merrill, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:Jennifer Rowell, MDJennifer Rowell, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina.Search for other works by this author on:
-
Case 36: A Case of Prolonged Hypoglycemia Due to Sulfonylurea and Concurrent Antibiotic UseByJennifer D. Merrill, MD;Jennifer D. Merrill, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, NCSearch for other works by this author on:Susan E. Spratt, MDSusan E. Spratt, MD1Duke University Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, NCSearch for other works by this author on:
-
-
Part 7: Cystic Fibrosis–Related Diabetes (CFRD)
-
Case 37: “Do I Really Need Insulin?” The Role of Insulin Therapy in Cystic Fibrosis– Related Diabetes (CFRD)ByNader Kasim, MD;Nader Kasim, MD1Department of Pediatrics, Division of Endocrinology and Diabetes, Helen Devos Children’s Hospital, Spectrum Health, Michigan State University, Grand Rapids, Michigan.Search for other works by this author on:Antoinette Moran, MD;Antoinette Moran, MD2Department of Pediatrics.Search for other works by this author on:Amir Moheet, MDAmir Moheet, MD3Department of Medicine, University of Minnesota, Minneapolis, MinnesotaSearch for other works by this author on:
-
Case 38: Cystic Fibrosis (CF)-Related Diabetes Case Series: Effects of the CF Transmembrane Conductance Regulator (CFTR) Modulator on Glycemic ControlByJagdeesh Ullal, MD;Jagdeesh Ullal, MD1University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Center for Diabetes and Endocrinology, Pittsburgh, Pennsylvania.Search for other works by this author on:Lina Merjaneh, MD;Lina Merjaneh, MD2Division of Endocrinology & Diabetes, Seattle Children’s Hospital, Seattle, Washington.Search for other works by this author on:Kara S. Hughan, MD;Kara S. Hughan, MD3Division of Endocrinology and Diabetes, University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.Search for other works by this author on:Andrea Kelly, MD, MSCEAndrea Kelly, MD, MSCE4Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PennsylvaniaSearch for other works by this author on:
-
-
Part 8: Diabetes Management and Miscellaneous Cases
-
Case 39: Simplifying Insulin Therapy: Transitioning from Basal-Bolus Insulin Therapy to Basal Insulin With a Glucagon-Like Peptide (GLP)-1 Receptor AnalogBySevil Aliyeva, MD;Sevil Aliyeva, MD1Division of Endocrinology, Medstar Union Memorial Hospital, Baltimore, MarylandSearch for other works by this author on:Pamela Schroeder, MD, PhD;Pamela Schroeder, MD, PhD1Division of Endocrinology, Medstar Union Memorial Hospital, Baltimore, MarylandSearch for other works by this author on:Paul Sack, MDPaul Sack, MD1Division of Endocrinology, Medstar Union Memorial Hospital, Baltimore, MarylandSearch for other works by this author on:
-
Case 40: Simplification of Insulin Regimen Improves Glycemic Control in Elderly Patients With Type 2 DiabetesByMaria Gracia Luzuriaga, MD;Maria Gracia Luzuriaga, MD1Division of Endocrinology, Diabetes, and Metabolism, University of Miami, Miller School of Medicine, Miami, FloridaSearch for other works by this author on:Rajesh Garg, MDRajesh Garg, MD1Division of Endocrinology, Diabetes, and Metabolism, University of Miami, Miller School of Medicine, Miami, FloridaSearch for other works by this author on:
-
Case 41: Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) in an Individual With Type 2 Diabetes on High-Dose Insulin TherapyByBasem M. Mishriky, MD;Basem M. Mishriky, MD1Department of Internal Medicine.Search for other works by this author on:Doyle M. Cummings, PharmD, FCP, FCCP;Doyle M. Cummings, PharmD, FCP, FCCP2Department of Family Medicine, East Carolina University, Greenville, North Carolina.Search for other works by this author on:Carlos E. Mendez, MDCarlos E. Mendez, MD3Division of Diabetes and Endocrinology, Froedtert and Medical College of Wisconsin, Milwaukee, WisconsinSearch for other works by this author on:
-
Case 42: Transient Severe Insulin Resistance in COVID-19 and PrediabetesByR. Matthew Hawkins, PA-C;R. Matthew Hawkins, PA-C1University of Colorado School of Medicine, Aurora, ColoradoSearch for other works by this author on:Whitney Adair, PA-C;Whitney Adair, PA-C1University of Colorado School of Medicine, Aurora, ColoradoSearch for other works by this author on:Joanna Gibbs, PA-C;Joanna Gibbs, PA-C1University of Colorado School of Medicine, Aurora, ColoradoSearch for other works by this author on:Jennifer Vinh, AGCNS-BC;Jennifer Vinh, AGCNS-BC1University of Colorado School of Medicine, Aurora, ColoradoSearch for other works by this author on:Cecilia C. Low Wang, MDCecilia C. Low Wang, MD1University of Colorado School of Medicine, Aurora, ColoradoSearch for other works by this author on:
-
Case 43: Nondiabetic Renal Disease in Type 1 Diabetes: When to Consider a Renal BiopsyByRong Mei Zhang, MD;Rong Mei Zhang, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:Ritika Puri, MD;Ritika Puri, MD2Division of Endocrinology, University of Nebraska Medical Center, Omaha, NebraskaSearch for other works by this author on:Tingting Li, MD;Tingting Li, MD3Division of Nephrology, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:Janet B. McGill, MDJanet B. McGill, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:
-
Case 44: Severe Fetal Malformation Related to Obesity and Type 2 DiabetesByAswathi Kumar, MD;Aswathi Kumar, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:Janet B. McGill, MDJanet B. McGill, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:
-
Case 45: Hyperglycemia from Oral Comfort FeedsByNehu Parimi, MD;Nehu Parimi, MD1Department of Endocrinology, University of Missouri, ColumbiaSearch for other works by this author on:Rajani Gundluru, MD;Rajani Gundluru, MD1Department of Endocrinology, University of Missouri, ColumbiaSearch for other works by this author on:Michael Gardner, MD;Michael Gardner, MD1Department of Endocrinology, University of Missouri, ColumbiaSearch for other works by this author on:James Sowers, MDJames Sowers, MD1Department of Endocrinology, University of Missouri, ColumbiaSearch for other works by this author on:
-
Case 46: Rethinking Insulin in Type 2 DiabetesByRebecca J. Morey, MD;Rebecca J. Morey, MD1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:Cynthia Herrick, MD, MPHSCynthia Herrick, MD, MPHS1Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MissouriSearch for other works by this author on:
-
Case 47: Coincidence or Consequence? A Case of Type 1 Diabetes With Worsening NeuropathyByCecilia C. Low Wang, MD, FACPCecilia C. Low Wang, MD, FACP1University of Colorado School of Medicine, Department of Medicine Division of Endocrinology, Metabolism and Diabetes, Anschutz Medical Campus, Aurora, ColoradoSearch for other works by this author on:
-
Case 48: Challenges to the Management of Diabetes in Patients Who Undergo Ventricular Assist Device (VAD) ImplantationByChinenye O. Usoh, MD;Chinenye O. Usoh, MD1Endocrinology and Metabolism Section.Search for other works by this author on:Donald A. McClain, MD, PhD;Donald A. McClain, MD, PhD1Endocrinology and Metabolism Section.Search for other works by this author on:Barbara A. Pisani, DOBarbara A. Pisani, DO2Cardiovascular Medicine Section, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.Search for other works by this author on:
-
Case 49: Insulin and Heroin: An Unfortunate Mix in an Overlooked PopulationByAmro Ilaiwy, MD;Amro Ilaiwy, MD1Division of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, North CarolinaSearch for other works by this author on:Jennifer V. Rowell, MD;Jennifer V. Rowell, MD1Division of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, North CarolinaSearch for other works by this author on:Beatrice D. Hong, MDBeatrice D. Hong, MD1Division of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, North CarolinaSearch for other works by this author on:
-